EXUMA Biotech to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
WEST PALM BEACH, Fla., Sept. 22, 2021 /PRNewswire/ -- Exuma Biotechnology Corp., a clinical-stage biotechnology company discovering and developing cell and gene therapies and delivery solutions for liquid and solid tumors, today announced that Chairman and Chief Executive Officer, Gregory Frost, Ph.D., will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021, from 2:40-3:10 p.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at https://wsw.com/webcast/cantor12/exum/2110710
An archived edition of the session will be available at exumabio.com for at least 30 days following the event.
About EXUMA Biotech
View original content to download multimedia:https://www.prnewswire.com/news-releases/exuma-biotech-to-present-at-the-2021-cantor-fitzgerald-virtual-global-healthcare-conference-301382154.html
SOURCE EXUMA Biotech Corp.